Eyonis Inc, a Median Technologies Company, Wins “Rising Star” Digital Health & AI Award for eyonis® LCS Lung Cancer Screening

SOPHIA ANTIPOLIS, France & LAS VEGAS–(BUSINESS WIRE)–Regulatory News: Median Technologies (FR0011049824, ALMDT, “Median” or the “Company”), developer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer detection and diagnosis, announced today that Eyonis Inc., its U.S. subsidiary has been selected a winner of the 2026 Digital Health Hub Foundation Digital Health & AI Awards. Eyonis was named a “Rising Star” in the “Cancer, Scree

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.